Journal of Heart and Lung Transplantation

Papers
(The H4-Index of Journal of Heart and Lung Transplantation is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation535
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial 256
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients159
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant115
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing105
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass101
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation97
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy84
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients84
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil77
Early Onset Malignancy in the First-Year After Heart Transplantation71
Older Donor Hearts for Heart Transplantation67
WITHDRAWN66
Comparative Analysis of Fontan Transplant Outcomes63
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension63
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report62
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes59
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience58
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD58
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation57
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients54
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade53
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome52
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients52
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status51
Utility of Breath Volatomic Analysis in Lung Transplant Recipients49
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models48
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD48
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis47
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation47
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion45
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience43
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY43
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES43
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation42
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial41
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation40
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients39
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support38
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation38
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis38
0.062674999237061